Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

The company on May 28 announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas (STS). CytRx Corporation (NASDAQ:CYTR) stock performance was -5.41% in last session and finished the day at $4.02. Traded volume was 9.62million shares … Continue reading Healthcare Losers: CytRx (NASDAQ:CYTR), Trivascular Technologies (NASDAQ:TRIV), Neuralstem (NYSEMKT:CUR), Ventrus Biosciences Inc (NASDAQ:VTUS)

Top Losers: StemCells (NASDAQ:STEM), CytRx (NASDAQ:CYTR), Neonode (NASDAQ:NEON), Halcon Resources (NYSE:HK), Yamana Gold (NYSE:AUY)

Research analysts at Maxim Group lifted their price target on shares of Stemcells Inc (NASDAQ:STEM) from $2.50 to $5.00 in a report released on Friday. The firm currently has a “buy” rating on the stock. Maxim Group’s price objective indicates a potential upside of 155.10% from the company’s current price. StemCells Inc (NASDAQ:STEM) stock performance was -6.12% in last session and finished the day at … Continue reading Top Losers: StemCells (NASDAQ:STEM), CytRx (NASDAQ:CYTR), Neonode (NASDAQ:NEON), Halcon Resources (NYSE:HK), Yamana Gold (NYSE:AUY)

CEL-SCI Corporation (NYSEMKT:CVM) announced that Geert Kersten Chief Executive Officer will be presenting at the 2014 BIO International Convention on Wednesday June 25th at 2:00 p.m. PDT. Hosted by the Biotechnology Industry Organization (BIO) this year’s global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego California. CEL-SCI Corporation (NYSEMKT:CVM) stock performance was -6.40% in last session … Continue reading Biotech Volatile Movements: CEL-SCI (NYSEMKT:CVM), NewLink Genetics (NASDAQ:NLNK), Alder Biopharmaceuticals (NASDAQ:ALDR), CytRx (NASDAQ:CYTR), StemCells Inc (NASDAQ:STEM)

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was 4.15million shares in the last session and the average volume … Continue reading Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

Bellatrix Exploration (NYSE:BXE) had its target price decreased by BMO Capital Markets from C$4.75 to C$3.75 in a report issued on Monday. They currently have a market perform rating on the stock. Bellatrix Exploration Ltd. (NYSE:BXE) belongs to Basic Materials sector. Its weekly performance is -18.82%. On last trading day company shares ended up $2.07. Bellatrix Exploration Ltd. (NYSE:BXE) distance from 50-day simple moving average … Continue reading What’s Hot: Bellatrix Exploration Ltd. (NYSE:BXE), Ametek Inc. (NYSE:AME), McDonald’s Corp. (NYSE:MCD), CytRx Corporation (NASDAQ:CYTR), Pacific Continental Corp. (NASDAQ:PCBK)

Extreme Networks Inc. (NASDAQ:EXTR) on Tuesday reported a loss of $19.3 million in its fiscal first quarter. The San Jose, California-based company said it had a loss of 20 cents per share. Losses, adjusted for amortization costs and stock option expense, came to 1 cent per share. Extreme Networks Inc. (NASDAQ:EXTR) in last trading activity moved up 10.00% to close at $3.63. Company weekly performance … Continue reading Investors Alert: Extreme Networks Inc. (NASDAQ:EXTR), The Dow Chemical Company (NYSE:DOW), PhotoMedex, Inc. (NASDAQ:PHMD), CytRx Corporation (NASDAQ:CYTR), Allied Nevada Gold Corp. (NYSEMKT:ANV)